Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€62.50
19.03.24
€80.00
19.03.25
-28.64%
06:36

WatchMen 
19.03.24 50%
buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€28.97
27.04.24
-
27.05.24
-
02:15

melinda 
27.04.24 50%
sell
Insmed Inc.

Start price
Target price
Perf. (%)
€20.40
26.05.24
€16.00
31.01.26
0.00%
00:42

Could be very worthwhile Investment >20% year
BiotechBee 
26.05.24 50%
buy
ImmunityBio Inc.

Start price
Target price
Perf. (%)
€5.05
31.03.24
€10.00
31.03.25
18.70%
27.05.24

WatchMen 
31.03.24 50%
sell
Insmed Inc.

Start price
Target price
Perf. (%)
€22.80
17.05.24
€18.00
28.02.26
-10.53%
26.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.05.24 50%
sell
Novavax Inc.

Start price
Target price
Perf. (%)
€12.05
15.05.24
€2.00
15.05.25
17.78%
26.05.24

marianka1001 
15.05.24 60%
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€4.66
24.05.24
-
24.05.25
-11.16%
25.05.24

Wolf_of_WS 
24.05.24 50%
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€5.80
29.11.23
-
29.11.24
-28.62%
25.05.24

Could be very worthwhile Investment >20% year
blaugold 
29.11.23 50%
sell
Savara Inc.

Start price
Target price
Perf. (%)
€4.34
15.05.24
-
15.05.25
-14.75%
25.05.24

blaugold 
15.05.24 50%
sell
Novavax Inc.

Start price
Target price
Perf. (%)
€11.90
13.05.24
-
13.05.25
19.28%
25.05.24

Bankster 
13.05.24 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€12.15
13.05.24
-
13.05.25
16.83%
25.05.24

Top 10 in its market
Could be worthwhile Investment >10% per year
Leading role in innovation
Very Future proof/growth oriented business model
kostojunior 
13.05.24 80%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.15
12.05.24
-
12.05.25
-21.69%
24.05.24

quelbe60 
12.05.24 50%
sell
T2 Biosystems Inc.

Start price
Target price
Perf. (%)
€0.066
23.05.23
-
23.05.24
148.41%
24.05.24

StockNews.com 
23.05.23 50%
buy
Chimerix Inc.

Start price
Target price
Perf. (%)
€1.44
22.05.23
-
22.05.24
-39.35%
23.05.24

Robert W. Baird 
22.05.23 50%
buy
Luna Innovations Inc.

Start price
Target price
Perf. (%)
€9.15
22.05.23
€9.24
22.05.24
-
23.05.24

Needham & Company LLC 
22.05.23 50%
buy
Orthofix Medical Inc.

Start price
Target price
Perf. (%)
€18.00
21.05.23
-
21.05.24
-27.22%
22.05.24

StockNews.com 
21.05.23 50%
buy
Addus Homecare Corp.

Start price
Target price
Perf. (%)
€80.50
20.05.23
-
20.05.24
24.22%
21.05.24

StockNews.com 
20.05.23 50%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€6.05
20.05.23
-
20.05.24
-63.97%
21.05.24

StockNews.com 
20.05.23 50%
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.18
31.03.24
€6.00
31.03.25
-31.58%
20.05.24

WatchMen 
31.03.24 50%
buy
Capricor Therapeutics Inc

Start price
Target price
Perf. (%)
€5.54
19.05.24
€10.00
-
20.05.24

mixitrader 
19.05.24 50%
sell
MacroGenics Inc.

Start price
Target price
Perf. (%)
€4.18
19.05.24
€2.00
-
20.05.24

nvestor 
19.05.24 50%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€22.03
20.05.23
-
20.05.24
177.89%
20.05.24

Shooter 
20.05.23 50%
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€5.88
19.05.23
€3.00
19.05.24
-61.56%
20.05.24

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
geldnutzer 
19.05.23 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€8.70
11.05.24
€82.00
11.05.25
39.26%
19.05.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
mixitrader 
11.05.24 50%
buy
Biolife Solutions Inc

Start price
Target price
Perf. (%)
€18.50
11.05.24
€32.00
11.05.25
8.11%
19.05.24

mixitrader 
11.05.24 50%